2min chapter

Blood Cancer Talks cover image

Episode 27. Management of PNH

Blood Cancer Talks

CHAPTER

Peg C2Cope Plan for CD55 and CD59

The good news is maybe not for that company, but I think that drug is going to go away in the sense that it's just too cumbersome for patients to use on a regular basis. There's oral complement inhibitors that are coming out that are also upstream that are probably going to take that option away. Even if her hemoglobin is 10.9, she's not having trouble with the always effective life. On the other hand, if she was 8.3 and is spending a lot of time in bed and fatigued and unable to do the things that she was doing before,. That's the type of patient I may offer something like Peg C2Cope plan that can actually address both

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode